Myrexis Inc. | Balance Sheet

Fiscal year is July-June. All values USD Thousands.
2009
2010
2011
2012
2013
Cash & Short Term Investments
169,100.00
138,876.00
105,635.00
88,378.00
1,210.00
Other Current Assets
240.00
453.00
1,861.00
1,166.00
27.00
Total Current Assets
169,340.00
139,329.00
107,496.00
89,544.00
1,237.00
Net Property, Plant & Equipment
5,338.00
5,996.00
3,315.00
649.00
-
Total Investments and Advances
18,905.00
8,577.00
10,243.00
1,248.00
-
Other Assets
94.00
206.00
206.00
210.00
-
Total Assets
193,677.00
154,108.00
121,260.00
91,651.00
1,237.00
Accounts Payable
-
1,927.00
1,210.00
197.00
-
Other Current Liabilities
4,576.00
2,323.00
2,100.00
2,082.00
74.00
Total Current Liabilities
4,576.00
4,250.00
3,310.00
2,279.00
74.00
Total Liabilities
4,576.00
4,250.00
3,310.00
2,279.00
74.00
Common Equity (Total)
189,101.00
149,858.00
117,950.00
89,372.00
1,163.00
Total Shareholders' Equity
189,101.00
149,858.00
117,950.00
89,372.00
1,163.00
Total Equity
189,101.00
149,858.00
117,950.00
89,372.00
1,163.00
Liabilities & Shareholders' Equity
193,677.00
154,108.00
121,260.00
91,651.00
1,237.00

About Myrexis

View Profile
Address
630 Fifth Avenue
New York New York 10020
United States
Employees -
Website http://www.myrexis.com
Updated 07/08/2019
Myrexis, Inc. is in the process of evaluating strategic alternatives, including focusing on identifying, evaluating and making financial investments in life sciences assets. The company was founded in January 2009 and is headquartered in New York, NY. .